Décideurs “private equity” 2021 ranks Ledouble as “Key actor” (“financial valuation”)
Assignments
Published on 21.09.2026
EUROBIO SCIENTIFIC
Ledouble acting as independent expert in the context of the public buyout offer followed by a squeeze-out to be launched by EB Development on Eurobio Scientific shares